The association between chronic hepatitis C(CHC)infection and extrahepatic manifestations(EHMs),particularly cardiometab......

BACKGROUND:In China,hepatitis C virus(HCV) infection is characterized by an increasing prevalence during aging.This stud......

Combination therapy with peginterferon (pegIFN)-α and ribavirin (RBV) has been the standard of care (SOC) for chronic h......

AIM To investigate peg-interferon(peg-IFN) and ribavirin(RBV) therapy in Myanmar and to predict sustained virologic resp......

Hepatitis C is an infection caused by the hepatitis C virus that attacks the liver and leads to inflammation. The curren......

AIM To evaluate new therapies for hepatitis C virus(HCV), data about real-world outcomes are needed.METHODS Outcomes of ......

The introduction of a direct-acting antiviral (DAA) for patients with hepatitis C virus (HCV) infection, could lead to h......

About 10 million people in China are infected with hepatitis C virus(HCV),with the seroprevalence of anti-HCV in the gen......

Introduction: In Senegal, the decentralization of Health Care Centers has contributed significantly to the intensificati......

Hepatitis C virus （HCV） was discovered 26 years ago.For decades, interferon-based therapy has been themainstay of treatmen......

In 2009,several groups reported that interleukin-28B(IL28B)genotypes are associated with the response to peginterferon p......